SCHEMBL5323906

SCHEMBL5323906

CC(N)(CN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10723687 0.97 KDM4E (0.56)
SCHEMBL9536247 0.86 HMGCR (0.55)
SCHEMBL21690012 0.79
SCHEMBL5324328 0.79
SCHEMBL7341356 0.79
SCHEMBL25295848 0.79
SCHEMBL289136 0.79
SCHEMBL8532783 0.77
SCHEMBL2039161 0.77 KDM4E (0.45)
SCHEMBL704537 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003666-B2 Hydrate for medical purposes DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-08-23 US disclosed
US-8003666-B2 Hydrate for medical purposes DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-08-23 US disclosed
US-20100234410-A1 HYDRATE FOR MEDICAL PURPOSES DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-20100234410-A1 HYDRATE FOR MEDICAL PURPOSES DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed
EP-0876161-A2 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1998-11-11 EP disclosed
WO-1997026921-A2 CONTRAST MEDIA NYCOMED SALUTAR INC. (US) 1997-07-31 WO disclosed